Replies to post #368466 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

You seem to have missed the fact that Anavex has multiple shots on goal.

Nope--haven't missed that or anything else. It's the multiple shots on goal that brought me into Anavex. In fact, I am counting on Anavex to ultimately rescue me if SAVA fails.

"A mediocre outcome is possible. Even then the SOC is so low that a mediocre outcome will likely result in an approval even if 2-73 is not the wonderful AD drug that is hoped."

I'm pretty comfortable you're not suggesting that trial results below stat sig could result in approval (without regard to the low SOC) because anything sort of stat sign on primary endpoints would certainly not be a "mediocre outcome". I believe that would considered an outright trial failure. Please correct me if you think that is not the case.

[JWC3]

Really! The P3 AD TRIAL has a very high probability of success. It will be more successful than P2 AD and PDD. Just hang onto your hats and don’t stand too close! Another way to say it is that failure has measure zero!